• AVEO Oncology is passionate in our pursuit of improving the lives of patients with cancer.

    Find out More

  • AVEO Oncology is passionate in our pursuit of improving the lives of patients with cancer.

    Find out More

  • AVEO Oncology is passionate in our pursuit of improving the lives of patients with cancer.

    Find out More

  • AVEO Oncology is passionate in our pursuit of improving the lives of patients with cancer.

    Find out More

  • ASCO Post: Brian I. Rini, MD, on Renal Cell Carcinoma: Results from the TIVO-3 Trial on Tivozanib vs Sorafenib (2019 Genitourinary Cancers Symposium; Feb. 14-16)
    Watch the video »

    TIVO-3: A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib to Sorafenib in Subjects with Refractory Advanced Renal Cell Carcinoma
    Download the presentation »